New grid could make cancer scans sharper, safer

NCT ID NCT04565457

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether a special 2D antiscatter grid can improve the quality of cone-beam CT (CBCT) images used during radiation therapy for prostate, head and neck, and upper abdomen cancers. 43 participants received one extra CBCT scan with the grid, and researchers compared image clarity, artifacts, and contrast to standard scans. The goal was to see if the grid reduces image errors and improves tissue visibility, which could help doctors target tumors more precisely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
2D antiscatter grid (device)
What this could lead to
If successful, this technology could improve image clarity in CBCT scans, potentially leading to more accurate radiation therapy targeting.
What could go wrong
This is a small pilot study focused on image quality, not patient outcomes. The improvement may not translate to better treatment results or be adopted widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Colorado Hospital

    Aurora, Colorado, 80045, United States

  • University of Florida Health Proton Therapy Institute

    Jacksonville, Florida, 32206, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.